Results 101 to 110 of about 63,671 (294)
Upadacitinib for difficult‐to‐treat paediatric Crohn's disease
Abstract Paediatric‐onset inflammatory bowel disease (IBD) has an enormous impact on healthcare systems as it translates to a lifetime of healthcare. Since the approval of anti‐tumour necrosis factor‐alpha agents, it has become evident that in the long journey of paediatric IBD, there is an absolute need for more treatment options.
N. Nedelkopoulou+3 more
wiley +1 more source
Abstract Background Dupilumab, inhibiting interleukin 4 and 13, is the first monoclonal antibody licensed for atopic dermatitis (AD) since 6 months of age. Objectives The study describes the patients' profile, the effectiveness and safety in real life of dupilumab in adolescents with moderate‐severe AD and children with severe AD.
Eulalia Baselga Torres+28 more
wiley +1 more source
ABSTRACT We report on a 31‐year‐old male patient diagnosed with active moderate‐to‐severe ulcerative colitis and a history of splenectomy. He was hospitalized due to confluent pustular oral lesions and multiple skin abscesses. After ruling out an infection, we diagnosed pyostomatitis vegetans associated with aseptic abscess syndrome.
C. Dandoy+6 more
wiley +1 more source
Rapid and Sustained Improvement of Lichen Planus Pemphigoides With the JAK1 Inhibitor Upadacitinib
ABSTRACT Lichen planus pemphigoides (LPP) is a rare autoimmune blistering disorder characteris ed by lichenoid plaques and blister formation. Current treatments are often ineffective, and there is a lack of standardised guidelines. The disease's pathogenesis involves both T‐cell‐mediated lichenoid dermatitis and autoantibody formation, presenting ...
Louise Gueissaz+2 more
wiley +1 more source
Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine [PDF]
Alfred DeMaria+2 more
openalex +1 more source
Azathioprine in Ulcerative Colitis: An Interim Report on a Controlled Therapeutic Trial [PDF]
D P Jewell, S. C. Truelove
openalex +1 more source
Abstract Background We reviewed the scientific literature to gain insight on the epidemiology and outcome of Strongyloides stercoralis infections after transplantation. Methods CINAHL, PUBMED, and OVID/MEDLINE were reviewed from inception through March 31, 2022 using key words Strongyloides and transplantation.
Cybele Lara R. Abad+3 more
wiley +1 more source
Genetics of drug‐induced liver injury: Current knowledge and future prospects
Abstract Idiosyncratic drug‐induced liver injury (DILI) remains an important clinical problem, both during drug development and the prescription of a range of licensed drugs. Although rare, the consequences are serious. Ongoing studies on genetic risk factors for DILI, especially genomewide association studies, have resulted in the identification of a ...
Ann K. Daly
wiley +1 more source